Loading organizations...
§ Venture Capital · Hengqin, Guangdong, China
Quancun Venture Capital is an investment firm.
Quancun Venture Capital functions as a venture capital firm, providing financial backing to companies primarily within the technology landscape. The firm is strategically located in Hengqin, Guangdong, China, positioning it within a dynamic region for technological innovation and growth.
Quancun Venture Capital is headquartered in Hengqin, Guangdong, China.
The firm has invested in companies like UniXell Biotechnology and a "star chip unicorn" that is reportedly heading for an IPO, suggesting an interest in growth-stage technology companies with significant market potential.
Quancun Venture Capital is headquartered in Hengqin, Guangdong, China.
The firm has invested in companies like UniXell Biotechnology and a "star chip unicorn" that is reportedly heading for an IPO, suggesting an interest in growth-stage technology companies with significant market potential.
The firm's investment portfolio includes companies such as UniXell Biotechnology, where it participated as one of several investors. This suggests an approach that may involve co-investing alongside other capital providers in syndicated funding rounds, supporting the development of biotechnology ventures.
Further demonstrating its investment scope, Quancun Venture Capital has also invested in a "star chip unicorn" based in Shenzhen. This particular company is noted for its potential to pursue an initial public offering (IPO), indicating the firm's interest in high-growth technology companies with clear pathways to market liquidity.
These investment patterns suggest Quancun Venture Capital focuses on sectors like biotechnology and semiconductors, targeting companies that exhibit strong growth potential and are advancing towards significant milestones such as public market debuts. The firm's role is to supply essential capital to these enterprises, fostering their expansion and innovation within the competitive technology market.
Quancun Venture Capital has 1 tracked investment across 1 company. The latest tracked deal is $7.2M Series A in UniXell Biotechnology in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 11, 2026 | UniXell Biotechnology | $7.2M Series A | — | PAN LIN Capital, Waigaoqiao Private Equity Fund |